Menopause Therapeutics Flashcards
What is systemic and local estrogen for?
Systemic (oral, transdermal): vasomotor symptoms
Local: for vulvovaginal atrophy
What are risks of using the first pass effect in systemic estrogen (oral pill instead of transdermal)
Increases:
- HDL cholesterol
- Triglycerides
- Coagulation factors
When are transdermal products used?
When at risk of:
- Hypertriglyceridemia
- High risk of VTE
- Malabsorption
- Obese women with metabolic syndrome
- Smokers
- history of gallstones
What are contraindications to estrogen therapy
- unexplained vaginal bleeding after 1 year of amenorrhea
- liver disease
- history of thromboembolic disease
- Estrogen-dependent cancer
- Pregnancy
- Coronary heart disease
- Previous stroke
When is follow up for estrogen
4-6 weeks
When is progestogen HT indicated?
Women with a uterus taking systemic ET
- prevents endometrial hyperplasia
- hyperplasia occurs within 6 months of ET if they do not take progesterone
What are CI of progestogens
- unexplained vaginal bleeding
- breast cancer
- pregnancy
- peanut allergy
- soy allergy
When do we give progestogen IUD
Estrogen + levonorgestrel
- if patients experiencing s/e to oral progestogen
- if they want contraception
What is the dosing like when using progestogen?
Cyclic for 5 years pre-menopause and 2 years post-menopause
- 2 weeks on, 2 weeks off
- to prevent BTB - although common
After 2 years post-menopause: continuous dosing
When are combo products used?
When patients are stabilized on a dose
- more difficult to taper
- daily pills
When to use COC in menopause?
Perimenopausal women if
- they need contraception
- useful when needing to control irregular or heavy bleeding
When is vaginal estrogen used?
For symptoms of vulvovaginal atrophy
- including dyspareunia
- urinary urge incontinence
- Recurrent UTIs
Must try systemic first
What are the CI of vaginal estrogen?
Not CI in women with CI to oral
- avoid in women with breast cancer and aromatase inhibitors
Which therapies are more risker for side effects
EPT vs ET
Oral vs transdermal
Risks:
EPT > ET
Oral > transdermal
When to treat or avoid HT in breast cancer? When does risk of breast cancer decrease?
Treat: risk of breast cancer
AVOID: if they had breast cancer
Risk decreases 3 years after stopping HRT